Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
21.79
+0.18 (0.83%)
Apr 9, 2026, 11:22 AM EDT - Market open
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $1.43 billion as of April 9, 2026. Its market cap has increased by 89.97% in one year.
Market Cap
1.43B
Enterprise Value
1.01B
1-Year Change
89.97%
Ranking
Category
Stock Price
$21.79
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has increased from $931.70M to $1.43B, an increase of 53.11%. That is a compound annual growth rate of 31.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 1.41B | 53.45% |
| Dec 31, 2025 | 921.98M | -2.74% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics | 1.48B |
| Nanobiotix | 1.47B |
| Precigen | 1.46B |
| Iovance Biotherapeutics | 1.43B |
| Immatics | 1.41B |
| Biohaven | 1.41B |
| Maze Therapeutics | 1.40B |
| Novavax | 1.37B |